Skip to main
KAPA
KAPA logo

KAPA Earnings Dates & Reports

KAPA Most Recent Earnings

Report DateMay 14, 2025
Period EndingQ1 2025
Est. EPS-$0.05
Actual EPS-$0.08
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KAPA Earnings per Share (EPS) History

Signup for full access
Browse free

KAPA Latest Earnings

The value each KAPA share was expected to gain vs. the value each share gained.

KAPA reported its most recent earnings on May 14, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.08. This exceeded analysts' expectations of -$0.05 by 60.00%, marking a Miss.

For comparison, Kairos Pharma Ltd reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/23/2025, with analysts projecting an EPS of -$0.05.

KAPA Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 23, 2025
-$0.05Next earnings call Aug. 23, 2025
Q1 2025May 14, 2025
-$0.05-$0.08+60.00%
DeckReportListen
Q4 2024Apr 14, 2025
-$0.02-$0.08+300.00%
Q3 2024Nov 13, 2024
-$0.10

KAPA Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Kairos Pharma Ltd’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 14, 2025
Apr 15, 2025
Nov 14, 2024

KAPA Earnings FAQs

KAPA last reported earnings on May 14, 2025 for Q1 2025, posting an EPS of -$0.08, which Miss the estimate of -$0.05 by 60.00%.

For Q1 2025, KAPA reported an EPS of -$0.08, missing analysts' estimate of -$0.05 by 60.00%.

For Q1 2025, KAPA Miss expectations with an actual EPS of -$0.08 vs. an estimated EPS of -$0.05.

Following the last earnings report on May 14, 2025, KAPA's stock price moved — from — to —.

The next KAPA earnings call is scheduled for Aug. 23, 2025, where executives will discuss financial results and outlook.

Kairos Pharma Ltd (KAPA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.